The global market for Chorionic Gonadotrophin for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Chorionic Gonadotrophin for Injection players cover Beijing Science Sun Pharmaceutical, Shenyang EverBright Pharmaceutical, Yantai Dongcheng Beifang Pharmaceutical, Livzon Pharmaceutical Group and Ningbo Renjian Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Chorionic Gonadotrophin for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Chorionic Gonadotrophin for Injection market, with both quantitative and qualitative data, to help readers understand how the Chorionic Gonadotrophin for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Chorionic Gonadotrophin for Injection market and forecasts the market size by Specification (1000U/Piece, 2000U/Piece and 5000U/Piece), by Application (Hospital Pharmacy, Retail Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
1000U/Piece
2000U/Piece
5000U/Piece
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Beijing Science Sun Pharmaceutical
Shenyang EverBright Pharmaceutical
Yantai Dongcheng Beifang Pharmaceutical
Livzon Pharmaceutical Group
Ningbo Renjian Pharmaceutical
Ma'anshan Fengyuan Pharmaceutical
Harbin High-Tech Group Baitian'er Pharmaceutical
Sinopharm
Besins Healthcare Benelux
Bristol Myers Squibb
Organon
Chapter Introduction
Chapter 1: Scope of Chorionic Gonadotrophin for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Chorionic Gonadotrophin for Injection market size (sales and revenue) and CAGR, Chorionic Gonadotrophin for Injection market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Chorionic Gonadotrophin for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Chorionic Gonadotrophin for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Chorionic Gonadotrophin for Injection market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Beijing Science Sun Pharmaceutical, Shenyang EverBright Pharmaceutical, Yantai Dongcheng Beifang Pharmaceutical, Livzon Pharmaceutical Group, Ningbo Renjian Pharmaceutical, Ma'anshan Fengyuan Pharmaceutical, Harbin High-Tech Group Baitian'er Pharmaceutical, Sinopharm and Besins Healthcare Benelux, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chorionic Gonadotrophin for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Chorionic Gonadotrophin for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Chorionic Gonadotrophin for Injection by Country/Region, 2017, 2022 & 2028
2.2 Chorionic Gonadotrophin for Injection Segment by Specification
2.2.1 1000U/Piece
2.2.2 2000U/Piece
2.2.3 5000U/Piece
2.3 Chorionic Gonadotrophin for Injection Sales by Specification
2.3.1 Global Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
2.3.2 Global Chorionic Gonadotrophin for Injection Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Chorionic Gonadotrophin for Injection Sale Price by Specification (2017-2022)
2.4 Chorionic Gonadotrophin for Injection Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Chorionic Gonadotrophin for Injection Sales by Application
2.5.1 Global Chorionic Gonadotrophin for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Chorionic Gonadotrophin for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Chorionic Gonadotrophin for Injection Sale Price by Application (2017-2022)
3 Global Chorionic Gonadotrophin for Injection by Company
3.1 Global Chorionic Gonadotrophin for Injection Breakdown Data by Company
3.1.1 Global Chorionic Gonadotrophin for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Chorionic Gonadotrophin for Injection Sales Market Share by Company (2020-2022)
3.2 Global Chorionic Gonadotrophin for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Chorionic Gonadotrophin for Injection Revenue by Company (2020-2022)
3.2.2 Global Chorionic Gonadotrophin for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Chorionic Gonadotrophin for Injection Sale Price by Company
3.4 Key Manufacturers Chorionic Gonadotrophin for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chorionic Gonadotrophin for Injection Product Location Distribution
3.4.2 Players Chorionic Gonadotrophin for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Chorionic Gonadotrophin for Injection by Geographic Region
4.1 World Historic Chorionic Gonadotrophin for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Chorionic Gonadotrophin for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Chorionic Gonadotrophin for Injection Annual Revenue by Geographic Region
4.2 World Historic Chorionic Gonadotrophin for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Chorionic Gonadotrophin for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Chorionic Gonadotrophin for Injection Annual Revenue by Country/Region
4.3 Americas Chorionic Gonadotrophin for Injection Sales Growth
4.4 APAC Chorionic Gonadotrophin for Injection Sales Growth
4.5 Europe Chorionic Gonadotrophin for Injection Sales Growth
4.6 Middle East & Africa Chorionic Gonadotrophin for Injection Sales Growth
5 Americas
5.1 Americas Chorionic Gonadotrophin for Injection Sales by Country
5.1.1 Americas Chorionic Gonadotrophin for Injection Sales by Country (2017-2022)
5.1.2 Americas Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022)
5.2 Americas Chorionic Gonadotrophin for Injection Sales by Specification
5.3 Americas Chorionic Gonadotrophin for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chorionic Gonadotrophin for Injection Sales by Region
6.1.1 APAC Chorionic Gonadotrophin for Injection Sales by Region (2017-2022)
6.1.2 APAC Chorionic Gonadotrophin for Injection Revenue by Region (2017-2022)
6.2 APAC Chorionic Gonadotrophin for Injection Sales by Specification
6.3 APAC Chorionic Gonadotrophin for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chorionic Gonadotrophin for Injection by Country
7.1.1 Europe Chorionic Gonadotrophin for Injection Sales by Country (2017-2022)
7.1.2 Europe Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022)
7.2 Europe Chorionic Gonadotrophin for Injection Sales by Specification
7.3 Europe Chorionic Gonadotrophin for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chorionic Gonadotrophin for Injection by Country
8.1.1 Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Specification
8.3 Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chorionic Gonadotrophin for Injection
10.3 Manufacturing Process Analysis of Chorionic Gonadotrophin for Injection
10.4 Industry Chain Structure of Chorionic Gonadotrophin for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chorionic Gonadotrophin for Injection Distributors
11.3 Chorionic Gonadotrophin for Injection Customer
12 World Forecast Review for Chorionic Gonadotrophin for Injection by Geographic Region
12.1 Global Chorionic Gonadotrophin for Injection Market Size Forecast by Region
12.1.1 Global Chorionic Gonadotrophin for Injection Forecast by Region (2023-2028)
12.1.2 Global Chorionic Gonadotrophin for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chorionic Gonadotrophin for Injection Forecast by Specification
12.7 Global Chorionic Gonadotrophin for Injection Forecast by Application
13 Key Players Analysis
13.1 Beijing Science Sun Pharmaceutical
13.1.1 Beijing Science Sun Pharmaceutical Company Information
13.1.2 Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
13.1.3 Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Beijing Science Sun Pharmaceutical Main Business Overview
13.1.5 Beijing Science Sun Pharmaceutical Latest Developments
13.2 Shenyang EverBright Pharmaceutical
13.2.1 Shenyang EverBright Pharmaceutical Company Information
13.2.2 Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
13.2.3 Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Shenyang EverBright Pharmaceutical Main Business Overview
13.2.5 Shenyang EverBright Pharmaceutical Latest Developments
13.3 Yantai Dongcheng Beifang Pharmaceutical
13.3.1 Yantai Dongcheng Beifang Pharmaceutical Company Information
13.3.2 Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
13.3.3 Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Yantai Dongcheng Beifang Pharmaceutical Main Business Overview
13.3.5 Yantai Dongcheng Beifang Pharmaceutical Latest Developments
13.4 Livzon Pharmaceutical Group
13.4.1 Livzon Pharmaceutical Group Company Information
13.4.2 Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Product Offered
13.4.3 Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Livzon Pharmaceutical Group Main Business Overview
13.4.5 Livzon Pharmaceutical Group Latest Developments
13.5 Ningbo Renjian Pharmaceutical
13.5.1 Ningbo Renjian Pharmaceutical Company Information
13.5.2 Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
13.5.3 Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ningbo Renjian Pharmaceutical Main Business Overview
13.5.5 Ningbo Renjian Pharmaceutical Latest Developments
13.6 Ma'anshan Fengyuan Pharmaceutical
13.6.1 Ma'anshan Fengyuan Pharmaceutical Company Information
13.6.2 Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
13.6.3 Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ma'anshan Fengyuan Pharmaceutical Main Business Overview
13.6.5 Ma'anshan Fengyuan Pharmaceutical Latest Developments
13.7 Harbin High-Tech Group Baitian'er Pharmaceutical
13.7.1 Harbin High-Tech Group Baitian'er Pharmaceutical Company Information
13.7.2 Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
13.7.3 Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Harbin High-Tech Group Baitian'er Pharmaceutical Main Business Overview
13.7.5 Harbin High-Tech Group Baitian'er Pharmaceutical Latest Developments
13.8 Sinopharm
13.8.1 Sinopharm Company Information
13.8.2 Sinopharm Chorionic Gonadotrophin for Injection Product Offered
13.8.3 Sinopharm Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sinopharm Main Business Overview
13.8.5 Sinopharm Latest Developments
13.9 Besins Healthcare Benelux
13.9.1 Besins Healthcare Benelux Company Information
13.9.2 Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Product Offered
13.9.3 Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Besins Healthcare Benelux Main Business Overview
13.9.5 Besins Healthcare Benelux Latest Developments
13.10 Bristol Myers Squibb
13.10.1 Bristol Myers Squibb Company Information
13.10.2 Bristol Myers Squibb Chorionic Gonadotrophin for Injection Product Offered
13.10.3 Bristol Myers Squibb Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bristol Myers Squibb Main Business Overview
13.10.5 Bristol Myers Squibb Latest Developments
13.11 Organon
13.11.1 Organon Company Information
13.11.2 Organon Chorionic Gonadotrophin for Injection Product Offered
13.11.3 Organon Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Organon Main Business Overview
13.11.5 Organon Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Chorionic Gonadotrophin for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Chorionic Gonadotrophin for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1000U/Piece
Table 4. Major Players of 2000U/Piece
Table 5. Major Players of 5000U/Piece
Table 6. Global Chorionic Gonadotrophin for Injection Sales by Specification (2017-2022) & (K Units)
Table 7. Global Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
Table 8. Global Chorionic Gonadotrophin for Injection Revenue by Specification (2017-2022) & ($ million)
Table 9. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Specification (2017-2022)
Table 10. Global Chorionic Gonadotrophin for Injection Sale Price by Specification (2017-2022) & (US$/Unit)
Table 11. Global Chorionic Gonadotrophin for Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Chorionic Gonadotrophin for Injection Sales Market Share by Application (2017-2022)
Table 13. Global Chorionic Gonadotrophin for Injection Revenue by Application (2017-2022)
Table 14. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Chorionic Gonadotrophin for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Chorionic Gonadotrophin for Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Chorionic Gonadotrophin for Injection Sales Market Share by Company (2020-2022)
Table 18. Global Chorionic Gonadotrophin for Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Chorionic Gonadotrophin for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Chorionic Gonadotrophin for Injection Producing Area Distribution and Sales Area
Table 22. Players Chorionic Gonadotrophin for Injection Products Offered
Table 23. Chorionic Gonadotrophin for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Chorionic Gonadotrophin for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Chorionic Gonadotrophin for Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Chorionic Gonadotrophin for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Chorionic Gonadotrophin for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Chorionic Gonadotrophin for Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Chorionic Gonadotrophin for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Chorionic Gonadotrophin for Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Chorionic Gonadotrophin for Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Chorionic Gonadotrophin for Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Chorionic Gonadotrophin for Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
Table 40. Americas Chorionic Gonadotrophin for Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Chorionic Gonadotrophin for Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Chorionic Gonadotrophin for Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Chorionic Gonadotrophin for Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Chorionic Gonadotrophin for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Chorionic Gonadotrophin for Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Chorionic Gonadotrophin for Injection Sales by Specification (2017-2022) & (K Units)
Table 47. APAC Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
Table 48. APAC Chorionic Gonadotrophin for Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Chorionic Gonadotrophin for Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Chorionic Gonadotrophin for Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Chorionic Gonadotrophin for Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Chorionic Gonadotrophin for Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Chorionic Gonadotrophin for Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
Table 56. Europe Chorionic Gonadotrophin for Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Chorionic Gonadotrophin for Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Chorionic Gonadotrophin for Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Chorionic Gonadotrophin for Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Specification (2017-2022) & (K Units)
Table 63. Middle East & Africa Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
Table 64. Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Chorionic Gonadotrophin for Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Chorionic Gonadotrophin for Injection
Table 67. Key Market Challenges & Risks of Chorionic Gonadotrophin for Injection
Table 68. Key Industry Trends of Chorionic Gonadotrophin for Injection
Table 69. Chorionic Gonadotrophin for Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Chorionic Gonadotrophin for Injection Distributors List
Table 72. Chorionic Gonadotrophin for Injection Customer List
Table 73. Global Chorionic Gonadotrophin for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Chorionic Gonadotrophin for Injection Sales Market Forecast by Region
Table 75. Global Chorionic Gonadotrophin for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Chorionic Gonadotrophin for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Chorionic Gonadotrophin for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Chorionic Gonadotrophin for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Chorionic Gonadotrophin for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Chorionic Gonadotrophin for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Chorionic Gonadotrophin for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Chorionic Gonadotrophin for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Chorionic Gonadotrophin for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Chorionic Gonadotrophin for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Chorionic Gonadotrophin for Injection Sales Forecast by Specification (2023-2028) & (K Units)
Table 86. Global Chorionic Gonadotrophin for Injection Sales Market Share Forecast by Specification (2023-2028)
Table 87. Global Chorionic Gonadotrophin for Injection Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 88. Global Chorionic Gonadotrophin for Injection Revenue Market Share Forecast by Specification (2023-2028)
Table 89. Global Chorionic Gonadotrophin for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Chorionic Gonadotrophin for Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Chorionic Gonadotrophin for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Chorionic Gonadotrophin for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Beijing Science Sun Pharmaceutical Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
Table 95. Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Beijing Science Sun Pharmaceutical Main Business
Table 97. Beijing Science Sun Pharmaceutical Latest Developments
Table 98. Shenyang EverBright Pharmaceutical Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
Table 100. Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Shenyang EverBright Pharmaceutical Main Business
Table 102. Shenyang EverBright Pharmaceutical Latest Developments
Table 103. Yantai Dongcheng Beifang Pharmaceutical Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
Table 105. Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Yantai Dongcheng Beifang Pharmaceutical Main Business
Table 107. Yantai Dongcheng Beifang Pharmaceutical Latest Developments
Table 108. Livzon Pharmaceutical Group Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Product Offered
Table 110. Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Livzon Pharmaceutical Group Main Business
Table 112. Livzon Pharmaceutical Group Latest Developments
Table 113. Ningbo Renjian Pharmaceutical Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
Table 115. Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Ningbo Renjian Pharmaceutical Main Business
Table 117. Ningbo Renjian Pharmaceutical Latest Developments
Table 118. Ma'anshan Fengyuan Pharmaceutical Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
Table 120. Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Ma'anshan Fengyuan Pharmaceutical Main Business
Table 122. Ma'anshan Fengyuan Pharmaceutical Latest Developments
Table 123. Harbin High-Tech Group Baitian'er Pharmaceutical Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
Table 125. Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Harbin High-Tech Group Baitian'er Pharmaceutical Main Business
Table 127. Harbin High-Tech Group Baitian'er Pharmaceutical Latest Developments
Table 128. Sinopharm Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Sinopharm Chorionic Gonadotrophin for Injection Product Offered
Table 130. Sinopharm Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Sinopharm Main Business
Table 132. Sinopharm Latest Developments
Table 133. Besins Healthcare Benelux Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Product Offered
Table 135. Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Besins Healthcare Benelux Main Business
Table 137. Besins Healthcare Benelux Latest Developments
Table 138. Bristol Myers Squibb Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Bristol Myers Squibb Chorionic Gonadotrophin for Injection Product Offered
Table 140. Bristol Myers Squibb Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Bristol Myers Squibb Main Business
Table 142. Bristol Myers Squibb Latest Developments
Table 143. Organon Basic Information, Chorionic Gonadotrophin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Organon Chorionic Gonadotrophin for Injection Product Offered
Table 145. Organon Chorionic Gonadotrophin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Organon Main Business
Table 147. Organon Latest Developments
List of Figures
Figure 1. Picture of Chorionic Gonadotrophin for Injection
Figure 2. Chorionic Gonadotrophin for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chorionic Gonadotrophin for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Chorionic Gonadotrophin for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Chorionic Gonadotrophin for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1000U/Piece
Figure 10. Product Picture of 2000U/Piece
Figure 11. Product Picture of 5000U/Piece
Figure 12. Global Chorionic Gonadotrophin for Injection Sales Market Share by Specification in 2021
Figure 13. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Specification (2017-2022)
Figure 14. Chorionic Gonadotrophin for Injection Consumed in Hospital Pharmacy
Figure 15. Global Chorionic Gonadotrophin for Injection Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 16. Chorionic Gonadotrophin for Injection Consumed in Retail Pharmacy
Figure 17. Global Chorionic Gonadotrophin for Injection Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 18. Chorionic Gonadotrophin for Injection Consumed in Others
Figure 19. Global Chorionic Gonadotrophin for Injection Market: Others (2017-2022) & (K Units)
Figure 20. Global Chorionic Gonadotrophin for Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Application in 2021
Figure 22. Chorionic Gonadotrophin for Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Company in 2021
Figure 24. Global Chorionic Gonadotrophin for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Chorionic Gonadotrophin for Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Chorionic Gonadotrophin for Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Chorionic Gonadotrophin for Injection Sales 2017-2022 (K Units)
Figure 29. Americas Chorionic Gonadotrophin for Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Chorionic Gonadotrophin for Injection Sales 2017-2022 (K Units)
Figure 31. APAC Chorionic Gonadotrophin for Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Chorionic Gonadotrophin for Injection Sales 2017-2022 (K Units)
Figure 33. Europe Chorionic Gonadotrophin for Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Chorionic Gonadotrophin for Injection Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Chorionic Gonadotrophin for Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Chorionic Gonadotrophin for Injection Sales Market Share by Country in 2021
Figure 37. Americas Chorionic Gonadotrophin for Injection Revenue Market Share by Country in 2021
Figure 38. United States Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Chorionic Gonadotrophin for Injection Sales Market Share by Region in 2021
Figure 43. APAC Chorionic Gonadotrophin for Injection Revenue Market Share by Regions in 2021
Figure 44. China Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Chorionic Gonadotrophin for Injection Sales Market Share by Country in 2021
Figure 51. Europe Chorionic Gonadotrophin for Injection Revenue Market Share by Country in 2021
Figure 52. Germany Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Chorionic Gonadotrophin for Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Chorionic Gonadotrophin for Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Chorionic Gonadotrophin for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Chorionic Gonadotrophin for Injection in 2021
Figure 65. Manufacturing Process Analysis of Chorionic Gonadotrophin for Injection
Figure 66. Industry Chain Structure of Chor
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)